Subjects: HEMORRAGIA SUBARACNOIDE, ANEURISMA INTRACRANIANO, ANTIDIABÉTICOS (HIPOGLICEMIANTES), ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Bruno Braga Sisnando da et al. Glibenclamide in aneurysmatic subarachnoid hemorrhage (GASH): study protocol for a randomized controlled trial. Trials, v. 20, 2019Tradução . . Disponível em: https://doi.org/10.1186/s13063-019-3517-y. Acesso em: 30 set. 2024.APA
Costa, B. B. S. da, Windlin, I. C., Koterba, E., Yamaki, V. N., Rabelo, N. N., Solla, D. J. F., et al. (2019). Glibenclamide in aneurysmatic subarachnoid hemorrhage (GASH): study protocol for a randomized controlled trial. Trials, 20. doi:10.1186/s13063-019-3517-yNLM
Costa BBS da, Windlin IC, Koterba E, Yamaki VN, Rabelo NN, Solla DJF, Teixeira MJ, Figueiredo EG. Glibenclamide in aneurysmatic subarachnoid hemorrhage (GASH): study protocol for a randomized controlled trial [Internet]. Trials. 2019 ; 20[citado 2024 set. 30 ] Available from: https://doi.org/10.1186/s13063-019-3517-yVancouver
Costa BBS da, Windlin IC, Koterba E, Yamaki VN, Rabelo NN, Solla DJF, Teixeira MJ, Figueiredo EG. Glibenclamide in aneurysmatic subarachnoid hemorrhage (GASH): study protocol for a randomized controlled trial [Internet]. Trials. 2019 ; 20[citado 2024 set. 30 ] Available from: https://doi.org/10.1186/s13063-019-3517-y